✦ LIBER ✦

A Phase I Study of Fludarabine, Cytarabine, and Oxaliplatin Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia

✍ Scribed by Tsimberidou, Apostolia Maria; Keating, Michael J.; Jabbour, Elias J.; Ravandi-Kashani, Farhad; O'Brien, Susan; Estey, Elihu; Bekele, Neby; Plunkett, William K.; Kantarjian, Hagop; Borthakur, Gautam

Book ID: 122286681
Publisher: Elsevier
Year: 2014
Tongue: English
Weight: 208 KB
Volume: 14
Category: Article
ISSN: 2152-2650
DOI: 10.1016/j.clml.2014.01.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fludarabine and cytarabine in patients w

Fludarabine and cytarabine in patients with relapsed acute myeloid leukemia refractory to initial salvage therapy

✍ McLaughlin, Brian; Im, Annie; Raptis, Anastasios; Agha, Mounzer; Hou, Jing-Zhou; 📂 Article 📅 2012 🏛 Carden Jennings Publishing 🌐 English ⚖ 186 KB

Phase I-II Clinical Trial of Oxaliplatin

Phase I-II Clinical Trial of Oxaliplatin, Fludarabine, Cytarabine, and Rituximab Therapy in Aggressive Relapsed/Refractory Chronic Lymphocytic Leukemia or Richter Syndrome

✍ Tsimberidou, Apostolia M.; Wierda, William G.; Wen, Sijin; Plunkett, William; O' 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 413 KB

Combination of topotecan with cytarabine

Combination of topotecan with cytarabine or etoposide in patients with refractory or relapsed acute myeloid leukemia: Results of a randomized phase I/II study

✍ Norbert Vey; Hagop Kantarjian; Miloslav Beran; Susan O'Brien; Jorge Cortes; Char 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 67 KB

A Phase I Trial of Lenalidomide in Combi

A Phase I Trial of Lenalidomide in Combination with Intermediate Dose Cytarabine (IDC) in Relapsed or Refractory Acute Myeloid Leukemia (AML) Patients

✍ Vigil, Carlos E.; Griffiths, Elizabeth A.; Thompson, James E.; Brady, William E. 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 64 KB

Twice-Daily Fludarabine and Cytarabine C

Twice-Daily Fludarabine and Cytarabine Combination With or Without Gentuzumab Ozogamicin is Effective in Patients With Relapsed/Refractory Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, and Blast- Phase Chronic Myeloid Leukemia

✍ Elias Jabbour; Guillermo Garcia-Manero; Jorge Cortes; Farhad Ravandi; William Pl 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 492 KB

Sequential continuous infusion of fludar

Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome®) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients

✍ Andrea Camera; Ciro R. Rinaldi; Salvatore Palmieri; Nicola Cantore; Giuseppina M 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 159 KB